Orosco M, Bremond J, Jacquot C, Cohen Y
Neuropharmacology. 1984 Feb;23(2A):183-8. doi: 10.1016/s0028-3908(84)80012-x.
Genetically obese Zucker rats and their lean litter mates were treated for 5 days with fenfluramine. Levels of noradrenaline (NA), dopamine (DA), 5-hydroxytryptamine (5-HT) and gamma-aminobutyric acid (GABA) and their metabolism were assayed in the hypothalamus, striatum, medulla-oblongata pons and remainder of the brain. Fenfluramine induced a slight increase in the level of NE in the hypothalamus in lean rats and a marked decrease in obese rats. No change in the synthesis of NE was found. Fenfluramine had no effect on the level and metabolism of DA. The levels of 5-HT were decreased by fenfluramine in obese and lean rats, and the metabolism was increased. The levels of GABA were not changed by fenfluramine. Synthesis of GABA was increased in the remainder of the brain of obese and lean rats. These data suggest that fenfluramine acts on 5-HT systems in both obese and lean rats and are consistent with reports of the pharmacological effects of fenfluramine.
将遗传性肥胖的 Zucker 大鼠及其瘦的同窝仔鼠用芬氟拉明处理 5 天。测定下丘脑、纹状体、延髓脑桥和脑的其余部分中去甲肾上腺素(NA)、多巴胺(DA)、5-羟色胺(5-HT)和γ-氨基丁酸(GABA)的水平及其代谢情况。芬氟拉明使瘦大鼠下丘脑 NE 水平略有升高,而肥胖大鼠下丘脑 NE 水平显著降低。未发现 NE 合成有变化。芬氟拉明对 DA 的水平和代谢无影响。肥胖和瘦大鼠的 5-HT 水平均因芬氟拉明而降低,且代谢增强。芬氟拉明对 GABA 水平无影响。肥胖和瘦大鼠脑的其余部分中 GABA 的合成增加。这些数据表明芬氟拉明对肥胖和瘦大鼠的 5-HT 系统均有作用,且与芬氟拉明药理作用的报道一致。